Literature DB >> 3258595

Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter.

A J Daniels1, J F Reinhard.   

Abstract

Chromaffin granules take up and concentrate 1-methyl-4-phenylpyridinium (MPP+) through a temperature-sensitive and saturable mechanism. The uptake displays an apparent Km of 51.2 microM and a Vmax of 7.1 nmol/min/mg of protein. MPP+ uptake is markedly depressed in the absence of ATP or by inhibition of the membrane Mg2+-dependent ATPase, and it is completely blocked by reserpine. Reversal of the membrane potential by carbonyl cyanide m-chlorophenylhydrazone or dissipation of the pH gradient in the presence of nigericin plus potassium ions produces a marked inhibition of MPP+ uptake indicating that the process is dependent upon the integrity of the transmembrane proton electrochemical gradient generated and maintained by the membrane Mg2+-dependent ATPase. Furthermore, the data shows that a permanently charged compound is capable of entering the granule through the catecholamine carrier.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258595

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Homology of a vesicular amine transporter to a gene conferring resistance to 1-methyl-4-phenylpyridinium.

Authors:  Y Stern-Bach; J N Keen; M Bejerano; S Steiner-Mordoch; M Wallach; J B Findlay; S Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 2.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

3.  High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.

Authors:  M K Sievert; D S Thiriot; R H Edwards; A E Ruoho
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

4.  Inward transport of 3H-MPP+ in freshly isolated rat hepatocytes: evidence for interaction with catecholamines.

Authors:  F Martel; M J Martins; I Azevedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

5.  Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.

Authors:  Guangrong Zheng; Linda P Dwoskin; Agripina G Deaciuc; Seth D Norrholm; Peter A Crooks
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

6.  Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells.

Authors:  Jun Tang Guo; An Qi Chen; Qi Kong; Hua Zhu; Chun Mei Ma; Chuan Qin
Journal:  Cell Mol Neurobiol       Date:  2007-11-06       Impact factor: 5.046

7.  Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine.

Authors:  A Vaccari; M Del Zompo; F Melis; G L Gessa; Z L Rossetti
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

8.  Vmat2 heterozygous mutant mice display a depressive-like phenotype.

Authors:  Masato Fukui; Ramona M Rodriguiz; Jiechun Zhou; Sara X Jiang; Lindsey E Phillips; Marc G Caron; William C Wetsel
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

9.  Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium.

Authors:  Y Liu; A Roghani; R H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

Review 10.  Disease-Toxicant Interactions in Parkinson's Disease Neuropathology.

Authors:  Gunnar F Kwakye; Rachael A McMinimy; Michael Aschner
Journal:  Neurochem Res       Date:  2016-09-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.